𝔖 Bobbio Scriptorium

✦ LIBER ✦

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Global Regulatory Guidelines for Vaccines

✍ Scribed by Plitnick, Lisa M.

Book ID: 120557338
Publisher: Elsevier
Year: 2013
Weight: 169 KB
Category: Article
ISBN: 012394810X
DOI: 10.1016/B978-0-12-394810-6.00009-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Introduction to Vaccines and Adjuvants

✍ Novicki, Deborah L. 📂 Article 📅 2013 🏛 Elsevier ⚖ 407 KB

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Nonclinical Development of Multi-targeting Biopharmaceuticals

✍ Prell, Rodney A. 📂 Article 📅 2013 🏛 Elsevier ⚖ 445 KB

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Special Considerations for the Nonclinical Safety Assessment of Vaccines

✍ Wolf, Jayanthi J. 📂 Article 📅 2013 🏛 Elsevier ⚖ 254 KB

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Overview of Biosimilar Therapeutics

✍ Herzyk, Danuta J. 📂 Article 📅 2013 🏛 Elsevier ⚖ 190 KB

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological Medicines

✍ Todd, Marque D. 📂 Article 📅 2013 🏛 Elsevier ⚖ 286 KB

Nonclinical Development of Novel Biologi

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics || Regulatory Standards for the Approval of Biosimilar Products

✍ Mounho-Zamora, Barbara 📂 Article 📅 2013 🏛 Elsevier ⚖ 486 KB